Overview
Bronchogen is a synthetic tetrapeptide engineered to act as a precision bioregulator for the respiratory system. Composed of L-alanyl-L-glutamyl-L-aspartyl-glycine (Ala-Glu-Asp-Gly, also known as AEDG), it is designed to mimic natural peptide signaling that directs the repair and maintenance of bronchial and lung tissues. Its primary function is to restore the structural integrity of the respiratory lining while normalizing the local immune response.
In research settings, this peptide has demonstrated a significant capacity to lower pro-inflammatory markers and improve the mechanical function of the lungs. By interacting with the genetic machinery of bronchial cells, it helps reverse age-related decline and damage caused by environmental stressors or chronic conditions. Unlike broad-spectrum anti-inflammatories, Bronchogen targets the specific cellular pathways responsible for airway health, offering a regenerative rather than just a symptomatic approach.
Mechanism of action
Acts as a tissue-specific bioregulator that interacts with DNA and histones to modulate gene expression, specifically upregulating lung-specific transcription factors like Hoxa3 to repair the respiratory epithelium and balance the pulmonary microenvironment.
Reported benefits
- ▸Reduces neutrophilic inflammation in lung tissue
- ▸Promotes regeneration of bronchial epithelium structure
- ▸Increases production of surfactant protein B for alveolar stability
- ▸Boosts mucosal immunity via increased secretory IgA (sIgA)
- ▸Supports DNA stabilization and healthy gene expression in aging cells
- ▸Helps restore mucociliary clearance and reduces excessive mucus load
Reported side effects
- ·Temporary flushing
- ·Transient heart rate increase (tachycardia) lasting minutes
- ·Mild headache
- ·Minimal injection site irritation
Often stacked with
BPC-157TB-500Epitalon